Skip to main content
. 2022 Aug 6;3(11):100389. doi: 10.1016/j.jtocrr.2022.100389

Figure 4.

Figure 4

OS and PFS by severity score of patient-reported lung cancer-associated symptoms at baseline. Illustrated are Kaplan-Meier estimates of OS and PFS in patients with symptom severity score less than or equal to the median (A and B) or greater than the median (C and D). Tick marks indicate censoring of data at the last time the patient was known to be alive. CI, confidence interval; HR, hazard ratio; NSQ-NSCLC, nonsquamous NSCLC; OS, overall survival; Pem, pemetrexed; Pembro, pembrolizumab; PFS, progression-free survival; Plat, platinum.